Receptor for hyaluronan‐mediated motility ( <scp>RHAMM</scp> ) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients

Sarah E Tarullo(University of Minnesota), Andrew C. Nelson(Genomics (United Kingdom))
The Journal of Pathology
April 26, 2023
Cited by 18


Related Papers